Ignite Creation Date:
2024-05-06 @ 3:46 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04750811
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-03-06
First Post:
2021-02-03
Brief Title:
A Danish Audit of Small Bowel Obstruction
Sponsor:
Danish Small Bowel Obstruction Collaborative
Organization:
Danish Small Bowel Obstruction Collaborative
Study Overview
Official Title:
A Danish Audit of Small Bowel Obstruction
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DASBO
Brief Summary:
Small bowel obstruction SBO is a common and potentially life-threatening acute surgical condition A minority of patients present with a clear indication for urgent surgical intervention either on the basis of clinical or radiological assessment clinical signs of peritonitissepsis suspicion of bowel ischaemia closed loop obstructions irreducible herniae etc However the optimal management of the remaining patients the majority of whom present with SBO caused by abdominal adhesions remains a topic of international debate with practice varying in different healthcare systems
This multicentre prospective observational study aims to describe the current management of patients admitted with SBO in 6 acute hospitals Bispebjerg Herlev Hillerød Hvidovre Køge Slagelse on the island of Sjælland Denmark which accounts for a 13 of the total Danish population
This multicentre prospective observational study aims to describe the current management of patients admitted with SBO in 6 acute hospitals Bispebjerg Herlev Hillerød Hvidovre Køge Slagelse on the island of Sjælland Denmark which accounts for a 13 of the total Danish population
Detailed Description:
This is a prospective non-interventional observational study of the management and outcomes of patients admitted with SBO in Denmark
Relevant clinicopathological demographics will be retrieved from consenting patients medical records An initial analysis will be performed once these patients have reached 90 days follow-up after the start of treatment The long-term outcomes of treatment will be assessed with further analyses at 1 3 and 5 years follow-up
Relevant clinicopathological demographics will be retrieved from consenting patients medical records An initial analysis will be performed once these patients have reached 90 days follow-up after the start of treatment The long-term outcomes of treatment will be assessed with further analyses at 1 3 and 5 years follow-up
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None